JPM23: After rock climbing in biotech, Novartis' CMO is back to support hopeful hike to US summit

Novartis' chief medical officer and global drug development president Shreeram Aradhye, M.D., is back after a muscle-building stint in biotech, jumping into 2023 laser-focused on five therapeutic areas and driven by the company’s goal of becoming a top U.S. drugmaker.